Abstract
Poly(ADP-ribose)polymerase-1 (PARP-1) is a nuclear protein activated by DNA damage. PARP-1 activation is associated in DNA repair, cell death and inflammation. Since oxidative stress induced robust DNA damage and wide spread inflammatory responses are common pathologies of various CNS diseases, the interest toward PARP-1 as a therapeutic target has peaked. This review introduces mechanism of PARP-1 activation, the role of PARP-1 in cell physiology and pathology, and discusses the potential of PARP-1 inhibition as a therapy in acute and chronic CNS diseases.
MeSH terms
-
Brain Death
-
Central Nervous System Diseases / enzymology*
-
Central Nervous System Diseases / genetics
-
Central Nervous System Diseases / pathology
-
DNA Repair*
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Inflammation
-
Nervous System Diseases / enzymology*
-
Nervous System Diseases / genetics
-
Nervous System Diseases / pathology
-
Poly (ADP-Ribose) Polymerase-1
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Poly(ADP-ribose) Polymerases / metabolism*
Substances
-
Enzyme Inhibitors
-
Poly(ADP-ribose) Polymerase Inhibitors
-
PARP1 protein, human
-
Poly (ADP-Ribose) Polymerase-1
-
Poly(ADP-ribose) Polymerases